Sign in
4

Changes in Ownership

IGC Pharma, Inc. Filed Acc 0001185185-18-001605

Exec. Chairman & CEO sold 200,000 shares at an average $1.04 ($207,098)

  • Exec. Chairman & CEO gave 160,000 shares (gift)
  • Exec. Chairman & CEO acquired 507,228 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MUKUNDA RAM · Exec. Chairman & CEO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2018-08-14 Gift : show line 1 in the form −160,000 $0.37 $59,200 1,999,760 D
2018-08-28 Sale : show line 2 in the form −125,000 $1.33 $166,000 1,874,760 D
2018-08-28 Grant or award : show line 3 in the form +400,000 2,274,760 D
2018-08-22 Sale : show line 4 in the form −50,000 $0.50 $25,105 410,189 I
2018-08-24 Sale : show line 5 in the form −25,000 $0.64 $15,993 385,189 I
2018-08-28 Grant or award : show line 6 in the form +107,228 492,417 I
Open-market sales · 200,000 sh · avg $1.04 · $207,098
Loading xslF345X03/ownership.xml…